(1)
Likmeta, M.; Shkoza, A.; Zguri, L.; Kraja, B. CHRONIC HEPATITIS C WITH SIGNIFICANT MORBIDITY AND END-ORGAN DAMAGE DEVELOPMENT DURING PEG-INTERFERON ALPHA-2A/RIBAVIRIN THERAPY. ESJ 2015, 11.